These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30066399)

  • 21. Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease.
    Qian X; Wang K; Wang X; Zheng SG; Lu L
    Int Immunopharmacol; 2011 May; 11(5):630-7. PubMed ID: 21147213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very Low Numbers of CD4
    Copsel S; Wolf D; Kale B; Barreras H; Lightbourn CO; Bader CS; Alperstein W; Altman NH; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1788-1794. PubMed ID: 29751114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
    Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
    Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity.
    Haug T; Aigner M; Peuser MM; Strobl CD; Hildner K; Mougiakakos D; Bruns H; Mackensen A; Völkl S
    Front Immunol; 2019; 10():883. PubMed ID: 31105702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression.
    Ford McIntyre MS; Young KJ; Gao J; Joe B; Zhang L
    J Immunol; 2008 Aug; 181(4):2271-5. PubMed ID: 18684915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice.
    Jin X; Hu M; Gong L; Li H; Wang Y; Ji M; Li H
    Mol Med Rep; 2018 Nov; 18(5):4457-4467. PubMed ID: 30221725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model.
    Adhikary SR; Cuthbertson P; Turner RJ; Sluyter R; Watson D
    Immunol Cell Biol; 2020 May; 98(5):397-410. PubMed ID: 32181525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function.
    Ulbar F; Montemurro T; Jofra T; Capri M; Comai G; Bertuzzo V; Lavazza C; Mandelli A; Viganò M; Budelli S; Bacalini MG; Pirazzini C; Garagnani P; Giudice V; Sollazzo D; Curti A; Arpinati M; La Manna G; Cescon M; Pinna AD; Franceschi C; Battaglia M; Giordano R; Catani L; Lemoli RM
    J Transl Med; 2019 Aug; 17(1):250. PubMed ID: 31383037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease.
    Han KL; Thomas SV; Koontz SM; Changpriroa CM; Ha SK; Malech HL; Kang EM
    J Immunol; 2013 Jan; 190(1):458-68. PubMed ID: 23225892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human regulatory T cells do not suppress the antitumor immunity in the bone marrow: a role for bone marrow stromal cells in neutralizing regulatory T cells.
    Guichelaar T; Emmelot ME; Rozemuller H; Martini B; Groen RW; Storm G; Lokhorst HM; Martens AC; Mutis T
    Clin Cancer Res; 2013 Mar; 19(6):1467-75. PubMed ID: 23382115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
    Giang S; Horwitz DA; Bickerton S; La Cava A
    Front Immunol; 2021; 12():628059. PubMed ID: 34122401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.
    Ford McIntyre MS; Gao JF; Li X; Naeini BM; Zhang L
    Int Immunopharmacol; 2011 May; 11(5):597-603. PubMed ID: 21109036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.
    Sugiyama H; Maeda Y; Nishimori H; Yamasuji Y; Matsuoka K; Fujii N; Kondo E; Shinagawa K; Tanaka T; Takeuchi K; Teshima T; Tanimoto M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):183-91. PubMed ID: 24333142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo.
    Pankratz S; Bittner S; Herrmann AM; Schuhmann MK; Ruck T; Meuth SG; Wiendl H
    FASEB J; 2014 Aug; 28(8):3435-45. PubMed ID: 24744146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells.
    Dijke IE; Hoeppli RE; Ellis T; Pearcey J; Huang Q; McMurchy AN; Boer K; Peeters AM; Aubert G; Larsen I; Ross DB; Rebeyka I; Campbell A; Baan CC; Levings MK; West LJ
    Am J Transplant; 2016 Jan; 16(1):58-71. PubMed ID: 26414799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling.
    Allgäuer A; Schreiner E; Ferrazzi F; Ekici AB; Gerbitz A; Mackensen A; Völkl S
    J Immunol; 2015 Oct; 195(7):3139-48. PubMed ID: 26324773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
    Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.
    Putnam AL; Safinia N; Medvec A; Laszkowska M; Wray M; Mintz MA; Trotta E; Szot GL; Liu W; Lares A; Lee K; Laing A; Lechler RI; Riley JL; Bluestone JA; Lombardi G; Tang Q
    Am J Transplant; 2013 Nov; 13(11):3010-20. PubMed ID: 24102808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells.
    Becker C; Taube C; Bopp T; Becker C; Michel K; Kubach J; Reuter S; Dehzad N; Neurath MF; Reifenberg K; Schneider FJ; Schmitt E; Jonuleit H
    Blood; 2009 Aug; 114(6):1263-9. PubMed ID: 19439734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.